FDA approves first MRI-safe pacemaker

February 8, 2011

The US Food and Drug Administration on Monday approved the first pacemaker system -- produced by medical device giant Medtronic Inc. -- that can be used safely with MRI scanners.

Patients with pacemakers, which generate electrical impulses to treat irregular or stalled heart beats, have had to forgo MRI scans because of the risk of the machines' radiowaves interfering with the heart devices.

Medtronic estimates that about 200,000 US pacemaker patients opt out of MRI scans every year even though they play a critical role in making a wide range of health diagnoses.

Its Revo MRI SureScan Pacing System has a function that can be turned on before a scan in order to prepare patients for the MRI machines, which can be up to 30,000 times more powerful than the Earth's magnetic field.

The function reduces or eliminates potential MRI hazards.

J. Rod Gimbel of Cardiology Associates of East Tennessee in Knoxville said the new pacemaker was "a major technological breakthrough for patients who need access to MRI."

"Providing pacemaker patients with access to MRI allows detection and treatment of serious medical conditions such as stroke, cancer and a wide variety of important neurologic and orthopedic conditions."

Medtronic said pacemaker use is growing as the population ages, with about five million patients worldwide currently outfitted with a pacemaker or implantable cardioverter-defibrillator. MRI use also has increased, with about 30 million scans completed in 2007.

"FDA's approval of the Revo represents an important step forward toward greater device innovation," said Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health.

"Those patients who meet the parameters for the device will be able to maintain their critical cardiac therapy while benefiting from the precise diagnostic capability of an MRI."

The FDA is requiring cardiologists and radiologists who use the system to receive appropriate training.

Related Stories

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.